Brandywine Global Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$152M Buy
1,584,743
+64,466
+4% +$6.26M 1.02% 19
2025
Q3
$145M Buy
1,520,277
+280,358
+23% +$25.8M 0.99% 17
2025
Q2
$108M Buy
1,239,919
+56,247
+5% +$4.77M 0.76% 28
2025
Q1
$106M Sell
1,183,672
-292,617
-20% -$26.2M 0.77% 28
2024
Q4
$118M Sell
1,476,289
-49,319
-3% -$4.27M 0.86% 25
2024
Q3
$137M Buy
1,525,608
+98,563
+7% +$8.29M 0.92% 24
2024
Q2
$112M Buy
1,427,045
+173,991
+14% +$14.3M 0.84% 24
2024
Q1
$109M Buy
1,253,054
+186,365
+17% +$15.9M 0.79% 29
2023
Q4
$87.9M Buy
1,066,689
+476,385
+81% +$36.3M 0.71% 30
2023
Q3
$46.3M Sell
590,304
-19,443
-3% -$1.63M 0.41% 74
2023
Q2
$53.7M Sell
609,747
-21,151
-3% -$1.82M 0.45% 63
2023
Q1
$50.9M Sell
630,898
-20,970
-3% -$1.71M 0.41% 68
2022
Q4
$50.7M Buy
651,868
+151,786
+30% +$12.3M 0.4% 71
2022
Q3
$40.4M Buy
500,082
+17,112
+4% +$1.54M 0.38% 78
2022
Q2
$43.3M Buy
482,970
+2,119
+0.4% +$215K 0.38% 82
2022
Q1
$53.4M Buy
480,851
+239,027
+99% +$25.3M 0.39% 73
2021
Q4
$25M Sell
241,824
-2,336
-1% -$271K 0.18% 140
2021
Q3
$30.6M Buy
244,160
+35,963
+17% +$4.65M 0.23% 121
2021
Q2
$25.8M Sell
208,197
-2,000
-1% -$251K 0.19% 136
2021
Q1
$24.8M Sell
210,197
-17,466
-8% -$2.05M 0.19% 140
2020
Q4
$26.7M Buy
227,663
+12,622
+6% +$1.39M 0.22% 122
2020
Q3
$22.3M Buy
215,041
+520
+0.2% +$52.2K 0.22% 116
2020
Q2
$19.7M Sell
214,521
-85
-0% -$8.15K 0.2% 118
2020
Q1
$19.4M Sell
214,606
-194,756
-48% -$20.7M 0.23% 100
2019
Q4
$46.9M Sell
409,362
-11,993
-3% -$1.32M 0.33% 75
2019
Q3
$45.8M Sell
421,355
-147,272
-26% -$15.4M 0.34% 73
2019
Q2
$55.4M Buy
+568,627
New +$51.9M 0.38% 66
2018
Q1
Sell
-60
Closed -$5K 937
2017
Q4
$5K Sell
60
-646,023
-100% -$51.7M ﹤0.01% 843
2017
Q3
$50.2M Sell
646,083
-10,828
-2% -$899K 0.32% 76
2017
Q2
$58.3M Buy
656,911
+28,636
+5% +$2.41M 0.37% 63
2017
Q1
$50.6M Buy
+628,275
New +$49.1M 0.32% 74
2016
Q4
Sell
-68
Closed -$6K 987
2016
Q3
$6K Hold
68
﹤0.01% 885
2016
Q2
$6K Hold
68
﹤0.01% 892
2016
Q1
$6K Sell
68
-61
-47% -$4.59K ﹤0.01% 926
2015
Q4
$10K Hold
129
﹤0.01% 872
2015
Q3
$9K Hold
129
﹤0.01% 915
2015
Q2
$10K Hold
129
﹤0.01% 913
2015
Q1
$11K Sell
129
-730,375
-100% -$55.4M ﹤0.01% 918
2014
Q4
$52.7M Buy
730,504
+62,640
+9% +$4.35M 0.35% 73
2014
Q3
$41.4M Buy
667,864
+115,060
+21% +$7.32M 0.3% 74
2014
Q2
$35.2M Buy
552,804
+75,210
+16% +$4.57M 0.28% 73
2014
Q1
$29.4M Buy
477,594
+2,394
+0.5% +$139K 0.26% 71
2013
Q4
$27.3M Buy
475,200
+5,450
+1% +$309K 0.25% 72
2013
Q3
$25M Buy
469,750
+42,920
+10% +$2.31M 0.25% 81
2013
Q2
$22M Buy
+426,830
New +$21.1M 0.23% 91

Other funds holding MDT

Brandywine Global Investment Management's MDT Position: Q4 2025 in Review

Brandywine Global Investment Management increased its Medtronic (MDT) stake by 4.2% in Q4 2025, buying an estimated $6.26M and bringing the position to 1,584,743 shares worth $152M. The position accounts for 1.02% of the portfolio, ranked #19.

Brandywine Global Investment Management first reported a position in MDT in Q2 2013 and has held it in 45 quarters since. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Brandywine Global Investment Management held 1,584,743 shares of Medtronic worth $152M as of Q4 2025.
  • Brandywine Global Investment Management bought 64,466 Medtronic shares in Q4 2025, an estimated $6.26M.
  • Medtronic made up 1.02% of Brandywine Global Investment Management's portfolio in Q4 2025, its #19 holding.
  • Brandywine Global Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 45 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.